Douglas RS - Search Results

1

Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Cockerham KP, Wester ST, Douglas RS, Dosiou C, Kossler AL. Shah SA, et al. Among authors: douglas rs. Ophthalmology. 2024 Jun;131(6):e27-e28. doi: 10.1016/j.ophtha.2024.01.003. Epub 2024 Feb 12. Ophthalmology. 2024. PMID: 38349298 No abstract available.

2

Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.

Sears CM, Wang Y, Bailey LA, Turbin R, Subramanian PS, Douglas R, Cockerham K, Kossler AL. Sears CM, et al. Am J Ophthalmol Case Rep. 2021 May 14;23:101111. doi: 10.1016/j.ajoc.2021.101111. eCollection 2021 Sep. Am J Ophthalmol Case Rep. 2021. PMID: 34113737 Free PMC article.

3

Infusion Center Guidelines for Teprotumumab Infusions: Informed Consent, Safety, and Management of Side Effects.

Kang J, Lechuga M, Braun J, Kossler A, Douglas R, Cockerham K. Kang J, et al. J Infus Nurs. 2021 Nov-Dec 01;44(6):331-338. doi: 10.1097/NAN.0000000000000446. J Infus Nurs. 2021. PMID: 34753152 Free PMC article.

4

Thyroid dermopathy responds to teprotumumab therapy.

Crespo-Trevino R, Schiffman J, Ugradar S, Cockerham K, Douglas R, de Leon-Garza D, Tang R. Crespo-Trevino R, et al. Endocrinol Diabetes Metab Case Rep. 2022 Mar 1;2022:21-0201. doi: 10.1530/EDM-21-0201. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2022. PMID: 35319490 Free PMC article.

5

A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface.

Ugradar S, Kossler AL, Douglas R, Cockerham K. Ugradar S, et al. J Neuroophthalmol. 2022 Mar 1;42(1):26-34. doi: 10.1097/WNO.0000000000001515. J Neuroophthalmol. 2022. PMID: 35500236 Review.

6

Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab.

Ugradar S, Zimmerman E, Parunakian E, Kang J, Cockerham K, Douglas RS. Ugradar S, et al. Among authors: douglas rs. Clin Exp Ophthalmol. 2023 May-Jun;51(4):339-348. doi: 10.1111/ceo.14208. Epub 2023 Feb 9. Clin Exp Ophthalmol. 2023. PMID: 36723406

7

Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study.

Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Dosiou C, Cockerham KP, Wester ST, Douglas RS, Kossler AL. Shah SA, et al. Among authors: douglas rs. Ophthalmology. 2024 Apr;131(4):458-467. doi: 10.1016/j.ophtha.2023.10.018. Epub 2023 Oct 16. Ophthalmology. 2024. PMID: 37852417

8

Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity.

Douglas RS, Couch S, Wester ST, Fowler BT, Liu CY, Subramanian PS, Tang R, Nguyen QT, Maamari RN, Ugradar S, Hsu K, Karon M, Stan MN. Douglas RS, et al. J Clin Endocrinol Metab. 2023 Dec 21;109(1):25-35. doi: 10.1210/clinem/dgad637. J Clin Endocrinol Metab. 2023. PMID: 37925673 Free PMC article. Clinical Trial.

9

The Rate of Re-treatment in Patients Treated with Teprotumumab: A Multicenter Study of 119 Patients with 1 Year of Follow-up.

Ugradar S, Parunakian E, Malkhasyan E, Chiou CA, Walsh HL, Tolentino J, Wester ST, Freitag SK, Douglas RS. Ugradar S, et al. Among authors: douglas rs. Ophthalmology. 2024 Jul 19:S0161-6420(24)00429-9. doi: 10.1016/j.ophtha.2024.07.018. Online ahead of print. Ophthalmology. 2024. PMID: 39032704

10

Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series.

Ugradar S, Parunakian E, Malkhasyan E, Raika P, Tolentino J, Kossler AL, Cockerham K, Amarikwa L, Weinberg DA, Douglas RS. Ugradar S, et al. Among authors: douglas rs. Graefes Arch Clin Exp Ophthalmol. 2024 Aug 13. doi: 10.1007/s00417-024-06599-3. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39136754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters